Eating after you stop
Quick answer. Weight usually comes back after stopping a GLP-1 medicine. In the STEP 1 extension people regained about two thirds of the weight they had lost within a year, and in SURMOUNT-4 people switched to placebo regained 14.0% of their body weight. Whether a particular way of eating prevents regain has not been tested in controlled trials, according to the 2025 advisory.
What usually happens
Many people stop a GLP-1 medicine at some point because of cost, side effects, insurance, pregnancy or reaching a goal. What happens to eating when the medicine stops matters, because the quiet appetite it created goes away too.
This page focuses on food and habits. The full numbers on regain, and the questions to ask a prescriber, are in the beginner guide chapter on stopping.
What trials show
In the STEP 1 extension, 327 people were followed for a year after stopping semaglutide 2.4 mg. They had lost 17.3% of their body weight on average, and a year later they had regained 11.6 percentage points of it, leaving a net loss of 5.6%. Blood pressure, cholesterol and blood sugar markers drifted back toward where they started.
In SURMOUNT-4, everyone took tirzepatide for 36 weeks and lost 20.9% on average. Over the next 52 weeks the group switched to placebo regained 14.0%, while the group that continued lost another 5.5%. A 2026 BMJ review of 37 studies and 9,341 people found people regained about 0.4 kg a month after stopping weight-management medicines, faster than after stopping a behavioral program.
The key limit is that these studies were not designed to test eating. Lifestyle support in the STEP 1 extension ended when treatment did, so it cannot separate the medicine from the support. The Atlas did not find a controlled trial of a specific eating plan after stopping a GLP-1 medicine.
What experts say about the time after
The 2025 advisory says weight regain is common after stopping, typically nearly to baseline within a year, and has been seen even with conventional nutrition counseling and behavioral therapy. It states that whether more structured nutrition and lifestyle therapy could reduce regain has not been studied in controlled trials.
It still recommends that clinicians help people build food, activity and sleep habits before and during treatment, so they can carry them forward if the medicine stops. It also says the best approach to nutrition for maintaining weight after stopping needs further study. The advisory highlights how common stopping is, with about 50% to 67% discontinuing at one year in real-world data.
A registered dietitian can help plan meals around the change, which is a good question to raise before stopping.
What people report
In online communities, people who have stopped describe appetite returning within weeks, food noise coming back, and a scramble to rebuild habits. The themes people commonly describe are weighing in more often, keeping protein high, lifting weights, tracking food, going down in dose instead of stopping outright, and asking for a dietitian.
People also describe what they wish they had done earlier: practicing portion sizes and regular meals while the appetite was quiet.
None of this was measured, and people who regain weight are less likely to post. It is here because it is a common story, not because any tactic is proven to work. Lowering the dose is a decision for your prescriber, and the trials above did not test a lower maintenance dose.
Who needs to be careful
- Anyone with diabetes, since blood sugar can rise after stopping and doses of other medicines may need to change.
- Anyone with high blood pressure or cholesterol, whose markers drifted back toward baseline in the trials.
- Anyone with a history of disordered eating, who should have support in place before the medicine stops.
- Anyone stopping suddenly because of cost or a shortage, who should ask for a plan.
Questions to bring to a clinician or dietitian
- If I stop, what is the plan for the first three months?
- Is a lower maintenance dose an option for me?
- How often should we check weight, blood pressure and blood sugar afterward?
- Can you refer me to a dietitian before I stop?
What is still unknown
- Whether any eating plan reduces regain after stopping has not been tested in controlled trials.
- Whether a slow taper or lower maintenance dose changes regain was not tested in the trials above.
- Results beyond one to two years are limited.
Related pages
Sources
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension Wilding JPH, et al. Diabetes Obes Metab. 2022;24(8):1553-1564. PMID 35441470. Funding: Novo Nordisk. Journal article
- Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4) Aronne LJ, et al. JAMA. 2024;331(1):38-48. PMID 38078870. Funding: Eli Lilly. Journal article
- Weight regain after cessation of medication for weight management: systematic review and meta-analysis West S, et al. BMJ. 2026;392:e085304. PMID 41500720. Funding: Not stated in the abstract. Journal article
- Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society Mozaffarian D, et al. Obes Pillars. 2025;15:100181. PMID 40673264. Funding: Professional societies; several authors report industry relationships. Journal article
- Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus Gorgojo-Martínez JJ, et al. J Clin Med. 2023;12(1):145. PMID 36614945. Funding: Not stated in the abstract. Journal article